Skip to main content

Global Opioids Agonist Drugs Market Is Estimated To Witness High Growth Owing To Rising Incidences of Chronic Pain & Increasing Use in Cancer Pain Management

Opioids Agonist Drugs Market 

The global opioids agonist drugs market is estimated to be valued at US$ 17,132.5 million in 2015 and is expected to exhibit a CAGR of 4.2% over the forecast period, as highlighted in a new report published by Coherent Market Insights.


A) Market Overview:
Opioids agonist drugs are commonly used for the treatment of moderate to severe pain. These drugs work by binding to opioid receptors in the central nervous system, thereby reducing the perception of pain. They are widely used for conditions such as chronic pain, cancer pain, and post-surgical pain management. The use of opioids agonist drugs is also increasing in palliative care to improve the quality of life for patients with advanced-stage diseases.

B) Market Dynamics:
The market for opioids agonist drugs is driven by two main factors. Firstly, the rising incidences of chronic pain are fueling the demand for effective pain management solutions. According to the National Institutes of Health, chronic pain affects approximately 50 million adults in the United States alone. This has led to an increased use of opioids agonist drugs for long-term pain management.

Secondly, the use of opioids agonist drugs in cancer pain management is also driving market growth. Cancer patients often experience severe pain due to the disease itself or treatment-related procedures. Opioids agonist drugs are considered the gold standard for cancer pain management, as they provide effective relief and improve the overall quality of life.

C) SWOT Analysis:
- Strength: Increasing demand for effective pain management solutions, wide range of opioids agonist drugs available in the market.
- Weakness: Potential for abuse and addiction, side effects and risk of overdose associated with opioids agonist drugs.
- Opportunity: Growing focus on the development of abuse-deterrent formulations and alternative pain management therapies.
- Threats: Stringent government regulations, increasing concern over the misuse of opioids agonist drugs.

D) Key Takeaways:
In terms of market size, the global Opioids Agonist Drugs Market is expected to witness high growth, exhibiting a CAGR of 4.2% over the forecast period, due to the increasing incidences of chronic pain and the rising use of opioids agonist drugs in cancer pain management.

In regional analysis, North America is expected to dominate the global opioids agonist drugs market, owing to the high prevalence of chronic pain and well-established healthcare infrastructure. However, the Asia Pacific region is expected to witness the fastest growth, driven by increasing awareness about pain management, growing healthcare expenditure, and improving access to healthcare facilities.

Key players operating in the global opioids agonist drugs market include Pfizer Inc., Purdue Pharma, Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Actavis Plc., Sanofi, Sun Pharmaceutical Industries Ltd., Mallinckrodt Pharmaceuticals, Egalet Corporation, and Endo Pharmaceuticals Inc. These companies are focusing on product innovation, strategic collaborations, and mergers & acquisitions to strengthen their market position.

In conclusion, the global opioids agonist drugs market is expected to witness significant growth in the coming years, driven by the rising incidences of chronic pain and the increasing use of opioids agonist drugs in cancer pain management. However, the market also faces challenges such as potential abuse and addiction, as well as stringent government regulations. To address these challenges, there is a growing focus on the development of abuse-deterrent formulations and alternative pain management therapies.
Labels:

Comments

Post a Comment

Popular posts from this blog

Revolutionizing Medicine: Exploring the Growing Bacteriophage Therapy Market

  Bacteriophage Therapy Market In recent years, medical science has witnessed a remarkable revolution in the field of infectious disease treatment - the rise of bacteriophage therapy. As antibiotic resistance continues to pose a global health threat, scientists and researchers are turning their attention to these tiny but powerful viruses to combat stubborn bacterial infections. What are Bacteriophages? Bacteriophages, or simply phages, are naturally occurring viruses that exclusively infect and kill bacteria. They have coexisted with bacteria for billions of years, playing a crucial role in maintaining microbial balance in nature. Harnessing this unique ability, scientists have now turned to phages as a promising alternative to antibiotics, especially against antibiotic-resistant superbugs that conventional medications struggle to combat. According to Coherent Market Insights, The global bacteriophage therapy market is estimated to be valued at US$ 1,148.6 million in 2020 and...
Post a Comment
Read more

Demystifying the Global Micro Guide Catheters Market: Trends and Forecasts

  Micro Guide Catheters Market The medical device industry is witnessing a paradigm shift, with advancements in technology driving innovation in various sectors. One such area that is gaining prominence is the micro guide catheters market. These tiny, flexible instruments have proven instrumental in navigating intricate vascular pathways and performing precise interventions. Trend 1: Miniaturization and Enhanced Flexibility As medical procedures become less invasive, the demand for micro guide catheters has surged. These catheters are designed to access the most challenging anatomical structures, providing medical professionals with greater precision and control during interventions. Miniaturization of the catheters allows for smoother navigation through tortuous vessels, minimizing the risk of vessel damage and reducing patient discomfort. Trend 2: Expanding Applications Initially, micro guide catheters found primary use in neurovascular interventions. However, their versa...
Post a Comment
Read more

Bile Duct Cancer Market: Increasing Awareness and Advances in Treatment Drive Market Growth

Bile Duct Cancer Market  The global Bile Duct Cancer Market is estimated to be valued at US$185.4 million in 2021 and is expected to exhibit a CAGR of 12.8% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights. Market Overview: Bile duct cancer, also known as cholangiocarcinoma, is a rare but aggressive form of cancer that affects the bile ducts, which are the tubes that carry bile from the liver to the small intestine. This cancer is challenging to diagnose and treat due to its location and aggressive nature. The market is driven by increasing awareness about bile duct cancer, advancements in diagnostic techniques, and the development of targeted therapies for the treatment of this condition. In terms of product use cases, the market offers various diagnostic tests, including imaging techniques like CT scan, MRI, and endoscopic retrograde cholangiopancreatography (ERCP). Additionally, therapeutic options include surgery, rad...
Post a Comment
Read more